{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:05:29Z","timestamp":1787317529826,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clae.2025.102381","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T14:53:32Z","timestamp":1739112812000},"page":"102381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Designing a contact lens with atropine base using a microemulsion technique"],"prefix":"10.1016","volume":"48","author":[{"given":"Md Abdullah","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan","family":"Maulvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditixa T.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kuppusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1197\/j.aem.2003.06.014","article-title":"Preparing for chemical terrorism: stability of injectable atropine sulfate","volume":"11","author":"Schier","year":"2004","journal-title":"Acad Emerg Med"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/08164622.2021.1877533","article-title":"Practical use and prescription of ocular medications in children and infants","volume":"104","author":"Webber","year":"2021","journal-title":"Clin Exp Optom"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/10903127.2016.1258098","article-title":"Hot and cold drugs: national park service medication stability at the extremes of temperature","volume":"21","author":"Armenian","year":"2017","journal-title":"Prehosp Emerg Care"},{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040588","article-title":"Corneal penetration of low-dose atropine eye drops","volume":"10","author":"Austermann","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clae.2025.102381_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2021.754889","article-title":"Microemulsions: unique properties, pharmacological applications, and targeted drug delivery","author":"Suhail","year":"2021","journal-title":"Front Nanotechnol"},{"key":"10.1016\/j.clae.2025.102381_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2021.753947","article-title":"Microemulsion based nanostructures for drug delivery","author":"Arredondo-Ochoa","year":"2022","journal-title":"Front Nanotechnol"},{"issue":"5","key":"10.1016\/j.clae.2025.102381_b0035","article-title":"Contact lens as an emerging platform for ophthalmic drug delivery: a systematic review","volume":"18","author":"Yang","year":"2023","journal-title":"Asian J Pharm Sci"},{"issue":"7","key":"10.1016\/j.clae.2025.102381_b0040","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1167\/iovs.03-0959","article-title":"Ophthalmic drug delivery through contact lenses","volume":"45","author":"Gulsen","year":"2004","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10.1016\/j.clae.2025.102381_b0045","article-title":"Bimatoprost loaded microemulsion laden contact lens to treat glaucoma","volume":"54","author":"Xu","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"10.1016\/j.clae.2025.102381_b0050","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3109\/10717544.2016.1138342","article-title":"A review on therapeutic contact lenses for ocular drug delivery","volume":"23","author":"Maulvi","year":"2016","journal-title":"Drug Deliv"},{"issue":"6","key":"10.1016\/j.clae.2025.102381_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11060262","article-title":"Effect of a cationic surfactant on microemulsion globules and drug release from hydrogel contact lenses","volume":"11","author":"Torres-Luna","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clae.2025.102381_b0060","article-title":"Travoprost loaded microemulsion soaked contact lenses: improved drug uptake, release kinetics and physical properties","volume":"57","author":"Xu","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.clae.2025.102381_b0070","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40123-019-00217-w","article-title":"Atropine 0.01% eye drops for myopia control in American children: a multiethnic sample across three US sites","volume":"8","author":"Larkin","year":"2019","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine forthetreatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.clae.2025.102381_b0085","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10792-020-01658-0","article-title":"Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children","volume":"41","author":"Zhao","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"9","key":"10.1016\/j.clae.2025.102381_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7090259","article-title":"The synergistic effects of orthokeratology and atropine in slowing the progression of myopia","volume":"7","author":"Wan","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.clae.2025.102381_b0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2023.2097","article-title":"Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial","author":"Zadnik","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jamaophthalmol.2017.6638","article-title":"Low-dose atropine for myopia control: considering all the data","volume":"136","author":"Bullimore","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0115","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/cxo.12967","article-title":"Which low-dose atropine for myopia control?","volume":"103","author":"Khanal","year":"2020","journal-title":"Clin Exp Optom"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","article-title":"Update in myopia and treatment strategy of atropine use in myopia control","volume":"33","author":"Wu","year":"2019","journal-title":"Eye (lond)"},{"issue":"8","key":"10.1016\/j.clae.2025.102381_b0125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year randomized clinical trial of misight lenses for myopia control","volume":"96","author":"Chamberlain","year":"2019","journal-title":"Optom vis Sci"},{"key":"10.1016\/j.clae.2025.102381_b0130","unstructured":"CooperVision. Start managing your child\u2019s myopia today; 2023. Available from: https:\/\/misight.com\/learn-about-myopia. [Accessed 23\/06\/2023 2023]."},{"key":"10.1016\/j.clae.2025.102381_b0135","unstructured":"FDA U. FDA approves first contact lens indicated to slow the progression of nearsightedness in children; 2023. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-contact-lens-indicated-slow-progression-nearsightedness-children. [Accessed 23\/06\/2023 2023]."},{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124535","article-title":"Orthokeratology to control myopia progression: a meta-analysis","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICL.0000000000000207","article-title":"Myopia control: a review","volume":"42","author":"Walline","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"7","key":"10.1016\/j.clae.2025.102381_b0150","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1167\/iovs.11-8453","article-title":"Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study","volume":"53","author":"Hiraoka","year":"2012","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0155","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ophtha.2014.09.028","article-title":"Myopia control during orthokeratology lens wear in children using a novel study design","volume":"122","author":"Swarbrick","year":"2015","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cxo.12666","article-title":"Optical and pharmacological strategies of myopia control","volume":"101","author":"Kang","year":"2018","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.clae.2025.102381_b0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/02713680590907256","article-title":"The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control","volume":"30","author":"Cho","year":"2005","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2415-14-141","article-title":"The control effect of orthokeratology on axial length elongation in Chinese children with myopia","volume":"14","author":"Zhu","year":"2014","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"10.1016\/j.clae.2025.102381_b0175","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1167\/iovs.13-12527","article-title":"Myopia control using toric orthokeratology (TO-SEE study)","volume":"54","author":"Chen","year":"2013","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"11","key":"10.1016\/j.clae.2025.102381_b0180","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.OPX.0000145028.53923.67","article-title":"Normal eye growth in emmetropic schoolchildren","volume":"81","author":"Zadnik","year":"2004","journal-title":"Optom vis Sci"},{"key":"10.1016\/j.clae.2025.102381_b0185","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2147\/OPTH.S370041","article-title":"Reduction of myopic progression using a multifocal soft contact lens: a retrospective cohort study","volume":"16","author":"Cooper","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3341\/kjo.2022.0125","article-title":"Peripheral defocus and myopia management: a mini-review","volume":"37","author":"Erdinest","year":"2023","journal-title":"Korean J Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/opo.12621","article-title":"Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2year results from a randomised clinical trial","volume":"39","author":"Sankaridurg","year":"2019","journal-title":"Ophthalmic Physiol Opt"},{"issue":"6","key":"10.1016\/j.clae.2025.102381_b0200","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s40123-022-00562-3","article-title":"Cost-effectiveness of presbyopia correction among seven strategies of bilateral cataract surgery based on a prospective single-blind two-center trial in China","volume":"11","author":"Lan","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"10.1016\/j.clae.2025.102381_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082371","article-title":"The combined effect of low-dose atropine with orthokeratology in pediatric myopia control: review of the current treatment status for myopia","volume":"9","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0210","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1159\/000519629","article-title":"Treatment of rapid progression of myopia: case series and literature review","volume":"12","author":"Erdinest","year":"2021","journal-title":"Case Rep Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0215","article-title":"Low-concentration atropine monotherapy vs. combined with MiSight 1 day contact lenses for myopia management","volume":"6","author":"Erdinest","year":"2022","journal-title":"Vision (basel)"},{"issue":"5","key":"10.1016\/j.clae.2025.102381_b0220","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/OPX.0000000000001884","article-title":"Effect of combining 0.01% atropine with soft multifocal contact lenses on myopia progression in children","volume":"99","author":"Jones","year":"2022","journal-title":"Optom vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0225","first-page":"157","article-title":"Role of atropine in the control of myopia progression- a review","volume":"7","author":"Kaiti","year":"2022","journal-title":"Beyoglu Eye J"},{"issue":"18","key":"10.1016\/j.clae.2025.102381_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26185577","article-title":"Soft contact lenses as drug delivery systems: a review","volume":"26","author":"Rykowska","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.clae.2025.102381_b0235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jconrel.2022.02.014","article-title":"Testing drug release from medicated contact lenses: The missing link to predict in vivo performance","volume":"343","author":"Pereira-da-Mota","year":"2022","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0240","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219419","article-title":"Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases","volume":"30","author":"Zhao","year":"2023","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.oftal.2019.07.009","article-title":"Contact lenses as drug-delivery systems: a promising therapeutic tool","volume":"95","author":"Holgado","year":"2020","journal-title":"Arch Soc Esp Oftalmol (engl Ed)"},{"issue":"11","key":"10.1016\/j.clae.2025.102381_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/polym10111221","article-title":"Strategies for improving ocular drug bioavailability and corneal wound healing with chitosan-based delivery systems","volume":"10","author":"Irimia","year":"2018","journal-title":"Polymers (basel)"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0255","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12951-023-02166-w","article-title":"Recent advancements in nanomaterial-laden contact lenses for diagnosis and treatment of glaucoma, review and update","volume":"21","author":"Baghban","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0260","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS Pharm Sci Tech"},{"issue":"6","key":"10.1016\/j.clae.2025.102381_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.101487","article-title":"Pharmaceutical-loaded contact lenses as an ocular drug delivery system: A review of critical lens characterization methodologies with reference to ISO standards","volume":"44","author":"Nguyen","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"7","key":"10.1016\/j.clae.2025.102381_b0270","article-title":"Use of ketotifen fumarate-eluting daily disposable soft contact lens in management of ocular allergy: literature review and report of two cases","volume":"14","author":"Ono","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.clae.2025.102381_b0275","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1177\/08853282231166858","article-title":"Atropine-eluting silicone contact lenses for myopia control","volume":"37","author":"Fu","year":"2023","journal-title":"J Biomater Appl"},{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0280","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/OPX.0000000000000807","article-title":"Atropine and roscovitine release from model silicone hydrogels","volume":"93","author":"Lasowski","year":"2016","journal-title":"Optom vis Sci"},{"key":"10.1016\/j.clae.2025.102381_b0285","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2147\/OPTH.S141404","article-title":"In vitro release of two anti-muscarinic drugs from soft contact lenses","volume":"11","author":"Hui","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2025.102381_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102246","article-title":"Absorption and attachment of atropine to etafilcon A contact lenses","volume":"47","author":"Abdullah Aziz","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.clae.2025.102381_b0295","article-title":"Techniques to enhance solubility of hydrophobic drugs: an overview","volume":"10","author":"Vimalson","year":"2016","journal-title":"Asian J Pharm"},{"key":"10.1016\/j.clae.2025.102381_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106226","article-title":"Novel quinazolinone disulfide analogues as pqs quorum sensing inhibitors against Pseudomonas aeruginosa","volume":"130","author":"Sabir","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.clae.2025.102381_b0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpba.2013.10.036","article-title":"Quantitative proton nuclear magnetic resonance for the structural and quantitative analysis of atropine sulfate","volume":"89","author":"Shen","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.clae.2025.102381_b0310","unstructured":"Stanford Research Systems I. Optimelt automated melting point system 2004, 2005. Available from: https:\/\/www.thinksrs.com\/downloads\/pdfs\/manuals\/MPA100m.pdf. [Accessed 03\/07\/2024 2024]."},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21608\/ajps.2023.332166","article-title":"Preparation and characterization of atropine sulfate orodispersible tablets","volume":"68","author":"Ibrahim","year":"2023","journal-title":"Al-Azhar j Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/j.clae.2025.102381_b0320","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijpharm.2017.03.083","article-title":"Effect of surfactant chain length on drug release kinetics from microemulsion-laden contact lenses","volume":"524","author":"Maulvi","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clae.2025.102381_b0325","unstructured":"LABTECH B. The multi-mode microplate reader for life science research.; 2016. Available from: https:\/\/brochures.bmglabtech.com\/view\/374020862\/. [Accessed 25\/07\/2024 2024]."},{"key":"10.1016\/j.clae.2025.102381_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110681","article-title":"Cyclosporine laden tailored microemulsion-gel depot for effective treatment of psoriasis: In vitro and in vivo studies","volume":"186","author":"Pandey","year":"2020","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.clae.2025.102381_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110632","article-title":"Lidocaine tripotassium phosphate complex laden microemulsion for prolonged local anaesthesia: In vitro and in vivo studies","volume":"185","author":"Maulvi","year":"2020","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0340","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clae.2020.03.015","article-title":"Thirty years of \u2018quiet eye\u2019 with etafilcon A contact lenses","volume":"43","author":"Efron","year":"2020","journal-title":"Cont Lens Anterior Eye"},{"issue":"29","key":"10.1016\/j.clae.2025.102381_b0345","doi-asserted-by":"crossref","first-page":"16578","DOI":"10.1039\/C9RA02858G","article-title":"Drug-eluting contact lens containing cyclosporine-loaded cholesterol-hyaluronate micelles for dry eye syndrome","volume":"9","author":"Mun","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.clae.2025.102381_b0350","unstructured":"BV O. Contact angle goniometer user manual; 2021. Available from: https:\/\/www.ossila.com\/pages\/contact-angle-goniometer-user-manual. [Accessed 29\/01\/2024 2024]."},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0355","doi-asserted-by":"crossref","first-page":"379","DOI":"10.55525\/tjst.1314368","article-title":"Measurement of ultraviolet light transmittance of different contact lens types","volume":"18","author":"Ate\u015f","year":"2023","journal-title":"Turk J Sci Technol"},{"key":"10.1016\/j.clae.2025.102381_b0360","doi-asserted-by":"crossref","unstructured":"Fuentes R, Fern\u00e1ndez E, Pascual I, Garc\u00eda C. UV-visible transmittance of silicone-hydrogel contact lenses measured with a fiber optic spectrometer. Proceedings of SPIE - The International Society for Optical Engineering. 8785. 2013.","DOI":"10.1117\/12.2025710"},{"key":"10.1016\/j.clae.2025.102381_b0365","unstructured":"ISO. Biological evaluation of medical devices \u2014 Part 5: Tests for in vitro cytotoxicity 2009. Available from: https:\/\/www.iso.org\/standard\/36406.html#lifecycle. [Accessed 06\/02\/2024 2024]."},{"issue":"71","key":"10.1016\/j.clae.2025.102381_b0370","doi-asserted-by":"crossref","first-page":"40611","DOI":"10.1039\/C8RA06175K","article-title":"In vitro biocompatibility analysis of functionalized poly(vinyl chloride)\/layered double hydroxide nanocomposites","volume":"8","author":"Singh","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.clae.2025.102381_b0375","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4102\/aveh.v72i1.41","article-title":"Repeatability and reproducibility of Tearlab measurements","volume":"72","author":"Gillan","year":"2013","journal-title":"Afr vis Eye Health"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0380","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/clpt.1988.155","article-title":"Systemic absorption of topically applied ocular atropine","volume":"44","author":"Lahdes","year":"1988","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2015.07.001","article-title":"The ocular immunology and uveitis foundation preferred practice patterns of uveitis management","volume":"61","author":"Foster","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"10.1016\/j.clae.2025.102381_b0390","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00417-018-4112-8","article-title":"Short-term effects of low-concentration atropine eye drops on pupil size and accommodation in young adult subjects","volume":"256","author":"Kaymak","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.clae.2025.102381_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13111571","article-title":"Advances in therapeutic contact lenses for the management of different ocular conditions","volume":"13","author":"Ioni\u021b\u0103","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.clae.2025.102381_b0400","doi-asserted-by":"crossref","DOI":"10.2174\/18743641-v17-e230214-2022-36","article-title":"Contact lens as drug delivery system for glaucoma treatment: a review","volume":"17","author":"Aljaberi","year":"2023","journal-title":"Open Ophthalmol J"},{"issue":"9","key":"10.1016\/j.clae.2025.102381_b0405","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/17425247.2021.1909568","article-title":"Atropine in topical formulations for the management of anterior and posterior segment ocular diseases","volume":"18","author":"Garc\u00eda Del Valle","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0410","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/15533174.2012.756027","article-title":"Spectroscopic investigation and reactivities of ruthenium (III) catalyzed oxidation of anticholinergic drug atropine sulfate monohydrate by hexacyanoferrate (III) in aqueous alkaline media: a mechanistic approach","volume":"44","author":"Meti","year":"2014","journal-title":"Syn React Inorg Metaorg Nanometal Chem"},{"key":"10.1016\/j.clae.2025.102381_b0415","series-title":"The Merck index","first-page":"148","author":"Susan","year":"1996"},{"issue":"3","key":"10.1016\/j.clae.2025.102381_b0420","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/0975-7406.84463","article-title":"Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system","volume":"3","author":"Thakkar","year":"2011","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.clae.2025.102381_b0425","doi-asserted-by":"crossref","unstructured":"Jones L, Brennan NA, Gonz\u00e1lez-M\u00e9ijome J, Lally J, Maldonado-Codina C, Schmidt TA, et al. The TFOS international workshop on contact lens discomfort: report of the contact lens materials, design, and care subcommittee. Invest Ophthalmol Vis Sci 2013;54(11):Tfos37-70. doi: 10.1167\/iovs.13-13215.","DOI":"10.1167\/iovs.13-13215"},{"issue":"12","key":"10.1016\/j.clae.2025.102381_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32491","article-title":"Physical properties of soft contact lens multipurpose solutions commercially available in Ghana","volume":"10","author":"Ilechie","year":"2024","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.clae.2025.102381_b0435","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1167\/iovs.03-0685","article-title":"Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers","volume":"44","author":"Glasson","year":"2003","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0440","doi-asserted-by":"crossref","first-page":"91","DOI":"10.33192\/Smj.2022.12","article-title":"Stability and sterility of extemporaneously prepared 0.01% atropine ophthalmic solution in artificial tears and balanced salt solution","volume":"74","author":"Sri-in","year":"2022","journal-title":"Siriraj Med J"},{"issue":"5","key":"10.1016\/j.clae.2025.102381_b0445","first-page":"460","article-title":"Biochemical, microbiological and phytochemical studies on aqueous-fermented extracts from Atropa belladonna L. Part 2\u2013Phytochemistry","volume":"67","author":"Schwarzenberger","year":"2012","journal-title":"Pharmazie"},{"issue":"8","key":"10.1016\/j.clae.2025.102381_b0450","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080781","article-title":"Stability of ophthalmic atropine solutions for child myopia control","volume":"12","author":"Berton","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0455","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.4103\/IJO.IJO_2778_22","article-title":"Contact lenses in dry eye disease and associated ocular surface disorders","volume":"71","author":"Chaudhary","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/ma12020261","article-title":"Contact lens materials: a materials science perspective","volume":"12","author":"Musgrave","year":"2019","journal-title":"Materials (basel)"},{"issue":"33","key":"10.1016\/j.clae.2025.102381_b0465","doi-asserted-by":"crossref","first-page":"29223","DOI":"10.1021\/acsomega.2c03310","article-title":"Sustained release of a polymeric wetting agent from a silicone-hydrogel contact lens material","volume":"7","author":"Zheng","year":"2022","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0470","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2003.12.009","article-title":"Determinants of eye drop size","volume":"49","author":"Van Santvliet","year":"2004","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2025.102381_b0475","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12886-017-0473-8","article-title":"An objective assessment of the variability in number of drops per bottle of glaucoma medication","volume":"17","author":"Moore","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2025.102381_b0480","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0039-6257(82)90081-9","article-title":"Pharmacokinetics of topically applied ophthalmic drugs","volume":"26","author":"Shell","year":"1982","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.clae.2025.102381_b0485","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/futurepharmacol4020019","article-title":"Ocular drug delivery into the eyes using drug-releasing soft contact lens","volume":"4","author":"Tashima","year":"2024","journal-title":"Future Pharmacol"},{"key":"10.1016\/j.clae.2025.102381_b0490","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.clae.2025.102381_b0495","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1021\/acsanm.3c05857","article-title":"Plasmonic contact lenses based on silver nanoparticles for blue light protection","volume":"7","author":"Elsherif","year":"2024","journal-title":"ACS Appl Nano Mater"},{"issue":"11","key":"10.1016\/j.clae.2025.102381_b0500","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048425000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048425000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T22:52:00Z","timestamp":1747263120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048425000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1367048425000153"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2025.102381","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing a contact lens with atropine base using a microemulsion technique","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2025.102381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}],"article-number":"102381"}}